Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
P2 : SHR-1210-II/III-HCC, 2020 | randomized controlled trial |
Qin Lancet Oncol 2020; 21:571-580 10.1016/S1470-2045(20)30011-5 |
|||
Checkmate 040, 0 | single-arm | single arm study |
El-Khoueiry AB Lancet 2017 Jun 24;389(10088):2492-2502. 10.1016/S0140-6736(17)31046-2 Yau T J Clin Oncol 2023; 41:1747-1757-. 10.1200/JCO.22.00972 |